12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

H7N9 VLP vaccine: Phase I started

Novavax began a single-blind, placebo-controlled Phase I trial evaluating 6 dose levels of 2 doses of intramuscular H7N9 VLP...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >